Sign in

CIK 0001557746

  • Non-accelerated filer
  • Smaller reporting company

Aclaris Therapeutics, Inc.

Sign in to watch
Ticker
ACRS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460571712
Phone
+1 484-324-7933
Business address
701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-03-01 Balthaser Kevin Chief Financial Officer Exercise or conversion +2,375 188,130
2026-03-01 Balthaser Kevin Chief Financial Officer Shares withheld for taxes −677 $2.87 $2K 187,453
2026-03-01 Balthaser Kevin Chief Financial Officer Exercise or conversion · Restricted Stock Units −2,375 0
2026-02-03 Balthaser Kevin Chief Financial Officer Exercise or conversion +22,025 192,204
2026-02-03 Balthaser Kevin Chief Financial Officer Shares withheld for taxes −6,449 $3.47 $22K 185,755
2026-02-03 Balthaser Kevin Chief Financial Officer Exercise or conversion · Restricted Stock Units −22,025 66,075
2026-02-02 Balthaser Kevin Chief Financial Officer Grant or award · Restricted Stock Units +99,100 99,100
2026-02-02 Balthaser Kevin Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +346,800 346,800
2026-02-01 Balthaser Kevin Chief Financial Officer Exercise or conversion +14,750 175,163
2026-02-01 Balthaser Kevin Chief Financial Officer Shares withheld for taxes −4,984 $3.51 $17K 170,179
2026-02-01 Balthaser Kevin Chief Financial Officer Exercise or conversion · Restricted Stock Units −14,750 29,500
2026-01-02 Balthaser Kevin Chief Financial Officer Exercise or conversion +13,200 164,874
2026-01-02 Balthaser Kevin Chief Financial Officer Shares withheld for taxes −4,461 $2.88 $13K 160,413
2026-01-02 Balthaser Kevin Chief Financial Officer Exercise or conversion · Restricted Stock Units −13,200 13,600
2026-01-01 Balthaser Kevin Chief Financial Officer Exercise or conversion +7,500 153,924
2026-01-01 Balthaser Kevin Chief Financial Officer Shares withheld for taxes −2,250 $3.01 $7K 151,674
2026-01-01 Balthaser Kevin Chief Financial Officer Exercise or conversion · Restricted Stock Units −7,500 7,500
2025-12-31 Balthaser Kevin Chief Financial Officer Exercise or conversion +73,750 166,358
2025-12-31 Balthaser Kevin Chief Financial Officer Shares withheld for taxes −19,934 $3.01 $60K 146,424
2025-12-31 Balthaser Kevin Chief Financial Officer Exercise or conversion · Restricted Stock Units −73,750 0

Page 1 of 4 · 74 trades